FindTrial
Sign In

Study on the Use and Side Effects of Pain-Relieving Medicines in Cancer Patients at a Tertiary Care Hospital in Haldwani, Uttarakhand

Prescribing Pattern And Safety Profile Of Analgesic Drugs For Pain Relief In Cancer Patients In Tertiary Care Teaching Hospital Haldwani Uttarakhand - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110261
Enrollment
205
Registered
2026-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Tanu Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to provide informed consent 2. both old and new cases 3. patients undergoing radiotherapy, chemotherapy, or palliative treatment 4. life expectancy of at least 4 weeks as assessed by the clinician

Exclusion criteria

Exclusion criteria: 1. Patients not willing to provide written informed consent 2. patients having renal and hepatic dysfunction 3. patients with pre-existing painful comorbidity such as diabetic neuropathy, trigeminal neuralgia, fibromyalgia

Design outcomes

Primary

MeasureTime frame
Reduction in Total Severity Pain Score at Subsequent Visit Will be Taken as Primary Outcome of DrugTimepoint: Baseline (1st visit), 2nd Week—

Secondary

MeasureTime frame
Incidence, causality, severity, preventability of adverse drug reactions associated with analgesic drugs used in cancer patients during the study period. Timepoint: Baseline (1st visit), 2nd week—

Countries

India

Contacts

Public ContactReena Bhardwaj

Government Medical College Haldwani

reenagbhardwaj@yahoo.co.in9997006882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026